Literature DB >> 1439810

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia.

J R Wetterau1, L P Aggerbeck, M E Bouma, C Eisenberg, A Munck, M Hermier, J Schmitz, G Gay, D J Rader, R E Gregg.   

Abstract

Abetalipoproteinemia is a human genetic disease that is characterized by a defect in the assembly or secretion of plasma very low density lipoproteins and chylomicrons. The microsomal triglyceride transfer protein (MTP), which is located in the lumen of microsomes isolated from the liver and intestine, has been proposed to function in lipoprotein assembly. MTP activity and the 88-kilodalton component of MTP were present in intestinal biopsy samples from eight control individuals but were absent in four abetalipoproteinemic subjects. This finding suggests that a defect in MTP is the basis for abetalipoproteinemia and that MTP is indeed required for lipoprotein assembly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439810     DOI: 10.1126/science.1439810

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  133 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

3.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.

Authors:  M Raabe; M M Véniant; M A Sullivan; C H Zlot; J Björkegren; L B Nielsen; J S Wong; R L Hamilton; S G Young
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 4.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 5.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

6.  Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.

Authors:  Zhiqiang Li; Yeun-Po Chiang; Mulin He; Ke Zhang; Jiao Zheng; Weihua Wu; Jiajia Cai; Yong Chen; Guangzhi Chen; Yunqin Chen; Jibin Dong; Tilla S Worgall; Xian-Cheng Jiang
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-02-02       Impact factor: 4.698

Review 7.  Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future.

Authors:  Evan A Stein; Frederick J Raal
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

8.  Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

Authors:  Masa-Aki Kawashiri; Hayato Tada; Marowa Hashimoto; Matsuo Taniyama; Takamitsu Nakano; Katsuyuki Nakajima; Takeshi Inoue; Mika Mori; Chiaki Nakanishi; Tetsuo Konno; Kenshi Hayashi; Atsushi Nohara; Akihiro Inazu; Junji Koizumi; Hirotaka Ishihara; Junji Kobayashi; Tsutomu Hirano; Hiroshi Mabuchi; Masakazu Yamagishi
Journal:  JIMD Rep       Date:  2015-03-13

9.  apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.

Authors:  L S Huang; E Voyiaziakis; D F Markenson; K A Sokol; T Hayek; J L Breslow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Common and rare gene variants affecting plasma LDL cholesterol.

Authors:  John R Burnett; Amanda J Hooper
Journal:  Clin Biochem Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.